Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Journal of Virology|July 13, 2007
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming programRosemary Tierney, Jasdeep Nagra, Isabel Hutchings, et al.Frontiers in Neurology|July 11, 2022
The Potential for EBV Vaccines to Prevent Multiple SclerosisPeter A Maple, Alberto Ascherio, Jeffrey I Cohen, et al.Plos Pathogens|August 22, 2014
Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycleLaura L Quinn, Jianmin Zuo, Rachel J M Abbott, et al.Journal of Pediatric Gastroenterology and Nutrition|November 24, 2020
Ferric Carboxymaltose Across All Ages in Paediatric Gastroenterology Shows Efficacy Without Increased Safety ConcernsNatasha Sasankan, Hazel Duncan, Lee Curtis, et al.Nucleic Acids Research|October 8, 2013
Epstein-Barr virus-mediated transformation of B cells induces global chromatin changes independent to the acquisition of proliferationHenar Hernando, Abul B M M K Islam, Javier Rodríguez-Ubreva, et al.Blood|October 8, 2008
Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cellsZania Stamataki, Claire Shannon-Lowe, Jean Shaw, et al.Plos Pathogens|January 3, 2009
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationJianmin Zuo, Andrew Currin, Bryan D Griffin, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2011
Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognitionHeather M Long, Alison M Leese, Odette L Chagoury, et al.Plos Pathogens|April 21, 2016
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic VaccinationJill M Brooks, Heather M Long, Rose J Tierney, et al.Elife|August 5, 2016
MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubsC David Wood, Hildegonda Veenstra, Sarika Khasnis, et al.Pageof 5